Literature DB >> 25406047

Adult ADHD vs. bipolar disorder in the DSM-5 era: a challenging differentiation for clinicians.

Michael J Brus1, Mary V Solanto, Joseph F Goldberg.   

Abstract

OBJECTIVE: Patients with adult attention-deficit/ hyperactivity disorder (ADHD) and bipolar disorder can present with similar symptoms, including increased energy, distractibility, disorganization, impulsivity, hyperactivity, and rapid speech. Determining whether the patient has either, or possibly both, of these syndromes can be a complex task. This review attempts to clarify where these disorders overlap, both symptomatically and epidemiologically, and where they diverge, to help clinicians increase the accuracy of their diagnoses. Changes to diagnostic criteria from the fourth to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (from DSM-IV-TR to DSM-5) are discussed, as is the evidence base for pharmacological treatments.
METHOD: Studies and sources were identified using computerized searches.
RESULTS: Adult ADHD and bipolar disorder have multiple overlapping symptoms, but there are differences in prevalence (ADHD affects 4.4% of adults in the United States versus 1.4% for bipolar disorder), onset of symptoms (usually before age 7 years in ADHD versus after age 12 years in bipolar disorder), disease course (chronic in ADHD versus cyclical in bipolar disorder), mood symptoms (absent in ADHD but always present in bipolar disorder), and psychotic symptoms (absent in ADHD but sometimes present in bipolar disorder). Approximately 20% of adult patients with ADHD also have bipolar disorder, while 10%-20% of patients with bipolar disorder have adult ADHD. Comorbidity of bipolar disorder and ADHD is associated with an earlier age of onset and a more chronic and disabling course of bipolar disorder, as well as more psychiatric comorbidity.
CONCLUSION: Distinguishing between adult ADHD and bipolar disorder requires careful attention to phenomenology and awareness of epidemiology, with a focus on childhood history, lifetime course of symptoms, and the possibility of comorbidity.

Entities:  

Mesh:

Year:  2014        PMID: 25406047     DOI: 10.1097/01.pra.0000456591.20622.9e

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  13 in total

Review 1.  Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder.

Authors:  Georgios Schoretsanitis; Jose de Leon; Chin B Eap; John M Kane; Michael Paulzen
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

3.  Questionnaire-based computational screening of adult ADHD.

Authors:  Arthur Trognon; Manon Richard
Journal:  BMC Psychiatry       Date:  2022-06-15       Impact factor: 4.144

4.  Suicidal and non-suicidal self-injurious behaviour in patients with bipolar disorder and comorbid attention deficit hyperactivity disorder after initiation of central stimulant treatment: a mirror-image study based on the LiSIE retrospective cohort.

Authors:  Louise Öhlund; Michael Ott; Robert Lundqvist; Mikael Sandlund; Ellinor Salander Renberg; Ursula Werneke
Journal:  Ther Adv Psychopharmacol       Date:  2020-08-06

Review 5.  Recent advances in the understanding and management of bipolar disorder in adults.

Authors:  Janusz K Rybakowski
Journal:  F1000Res       Date:  2017-11-21

Review 6.  MMPs in learning and memory and neuropsychiatric disorders.

Authors:  Anna Beroun; Shiladitya Mitra; Piotr Michaluk; Barbara Pijet; Marzena Stefaniuk; Leszek Kaczmarek
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

7.  Remote assessment in adults with Autism or ADHD: A service user satisfaction survey.

Authors:  Marios Adamou; Sarah L Jones; Tim Fullen; Nazmeen Galab; Karl Abbott; Salma Yasmeen
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

8.  Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder.

Authors:  Kevin S O'Connell; Alexey Shadrin; Shahram Bahrami; Olav B Smeland; Francesco Bettella; Oleksandr Frei; Florian Krull; Ragna B Askeland; G Bragi Walters; Katrín Davíðsdóttir; Gyða S Haraldsdóttir; Ólafur Ó Guðmundsson; Hreinn Stefánsson; Chun C Fan; Nils Eiel Steen; Ted Reichborn-Kjennerud; Anders M Dale; Kári Stefánsson; Srdjan Djurovic; Ole A Andreassen
Journal:  Mol Psychiatry       Date:  2019-12-02       Impact factor: 15.992

9.  The Quantified Behavioral Test-A Confirmatory Test in the Diagnostic Process of Adult ADHD?

Authors:  Nathalie Brunkhorst-Kanaan; Moritz Verdenhalven; Sarah Kittel-Schneider; Isabella Vainieri; Andreas Reif; Oliver Grimm
Journal:  Front Psychiatry       Date:  2020-03-20       Impact factor: 4.157

Review 10.  ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications.

Authors:  Virginio Salvi; Enrico Ribuoli; Michele Servasi; Laura Orsolini; Umberto Volpe
Journal:  Medicina (Kaunas)       Date:  2021-05-10       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.